ISPC
iSpecimen Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.54
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 466.3K | 1.9M | 9.3M | 9.9M | 10.4M |
| Cost of Revenue | 1.2M | 1.9M | 5.3M | 4.8M | 4.8M |
| Gross Profit | (706.3K) | 24.1K | 4.0M | 5.1M | 5.6M |
| Operating Expenses | |||||
| R&D Expense | (154.6K) | 2.2M | 3.5M | 3.6M | 2.7M |
| SG&A Expense | 6.7M | 6.6M | 12.6M | 11.7M | 12.4M |
| General & Admin Expense | 2.9M | 4.3M | 7.7M | 7.7M | 8.9M |
| Selling & Marketing Expense | 3.8M | 2.3M | 4.9M | 4.0M | 3.4M |
| Other Expenses | 2.2M | 247.0K | 537.9K | 1.0M | 801.1K |
| Total Operating Expenses | 8.7M | 9.0M | 16.7M | 16.3M | 15.8M |
| Cost and Expenses | 9.9M | 10.9M | 22.0M | 21.1M | 20.6M |
| Operating Income (EBIT) | (9.4M) | (9.0M) | (12.7M) | (11.2M) | (10.2M) |
| Non-Operating | |||||
| Interest Income | 3.2K | 3.7K | 44.1K | 339.8K | 169.3K |
| Interest Expense | 2.4K | 1.9K | 220.1K | 230.8K | 239.0K |
| Net Interest Income | 818.00 | 1.8K | (175.9K) | 109.0K | (69.6K) |
| Other Non-Op Income/Expense | (2.0M) | (1.5M) | 230.2K | 69.9K | (59.8K) |
| Non-Operating Income (excl Interest) | 2.0M | 1.5M | (56.5K) | (300.6K) | (179.1K) |
| EBT (Pre-Tax Income) | (11.4M) | (10.5M) | (12.5M) | (11.1M) | (10.2M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (11.4M) | (10.5M) | (12.5M) | (11.1M) | (10.2M) |
| Earnings from Cont. Ops | (11.4M) | (10.5M) | (12.5M) | (11.1M) | (10.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (11.4M) | (10.5M) | (12.5M) | (11.1M) | (10.2M) |
| Per Share | |||||
| Basic EPS | ($50.28) | ($91.15) | ($703.26) | ($982.11) | ($926.78) |
| Diluted EPS | ($50.28) | ($91.15) | ($703.26) | ($982.11) | ($926.78) |
| Revenue Per Share | $0.33 | $16.77 | $522.82 | $878.52 | $940.96 |
| Shares | |||||
| Basic Shares Outstanding | 1.4M | 115061 | 17771 | 11301 | 11055 |
| Diluted Shares Outstanding | 1.4M | 115061 | 17771 | 11301 | 11055 |
| Profitability Metrics | |||||
| EBITDA | (10.2M) | (8.7M) | (10.4M) | (8.8M) | (8.8M) |
| D&A | 1.2M | 1.7M | 2.3M | 2.1M | 1.2M |
| EBIT | (11.4M) | (10.5M) | (12.7M) | (10.9M) | (10.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026